Strategic collaboration combines Nurix’s leadership in targeted protein degradation with Roche’s portfolio of B-cell targeted therapies and global clinical and commercialization footprint ...

Two separate incidents involving two different political leanings, both pointing in the same direction. When you try forcing ...